THERMO FISHER SCIENTIFIC INC overview

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the fourth quarter and full year 2024 before the market opens on Thursday, January 30, 2025, and will hold a conference call on the same day at 8:30 a.m. EST. During the call, the company will discuss its financial performance, as well as future expectations. To listen, call (833) 470-1428 within the U.S. or (404) 975-4839 outside the U.S. The access code is...

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed the repurchase of $1 billion (1.9 million shares) of its common stock. As of December 3, 2024, $3 billion remained available under the company’s share repurchase authorization. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the...

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized the repurchase of $4 billion of shares of its common stock in the open market or in negotiated transactions. The authorization has no expiration date. This replaces the company’s existing repurchase authorization, of which $1 billion was remaining. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with...

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the Wolfe Healthcare Conference on Tuesday, November 19, 2024 at 8:00 a.m. (EDT). You can access the live webcast of the presentation via the Investors section of our website, www.thermofisher.com . About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over...

Thermo Fisher Scientific, National University Hospital and Mirxes Collaborate to Enhance Access to Advanced Genomic Testing for Early Cancer Detection in Singapore PR Newswire SINGAPORE, June 18, 2024 Partnership Aims to Personalize Cancer Care Tailored to the Needs of Southeast Asian Population to Provide Better Individualized Care SINGAPORE , June 18, 2024 /PRNewswire/ -- To increase patient access to affordable, advanced genomic testing for cancer in Singapore , Thermo Fisher Scientific Inc.,...

BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC PR Newswire MINNEAPOLIS, April 29, 2024 MINNEAPOLIS , April 29, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities is pleased to announce a significant milestone in its commitment to providing cutting-edge solutions to its customers. Effective May 1, 2024 , Bio-Techne will enter...

EDX MEDICAL ANNOUNCES COLLABORATION WITH THERMO FISHER SCIENTIFIC TO DEVELOP INNOVATIVE CANCER TESTS FOR GLOBAL HEALTHCARE MARKETS PR Newswire CAMBRIDGE, England, Nov. 21, 2023 CAMBRIDGE, England , Nov. 21, 2023 /PRNewswire/ -- EDX Medical Group ("EDX Medical"), a developer of innovative digital diagnostic products and services for personalised treatment of cancer, heart disease and infectious diseases, today announced it has entered into a collaborative agreement with Thermo Fisher Scientific...

Devyser and Thermo Fisher Scientific collaborate to promote laboratory services to advance pharmaceutical research PR Newswire STOCKHOLM, Sept. 13, 2023 STOCKHOLM , Sept. 13, 2023 /PRNewswire/ -- Devyser and Thermo Fisher Scientific have entered into a collaboration agreement to promote laboratory services. The goal is to partner with pharmaceutical companies to support their development projects utilising Devyser's unique assays in its CLIA-certified laboratory. The companies will work together...